PRIME PsO

PRIME PsO

This is a Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis. If you participate in this clinical trial you will undergo one-day screening during 28 day screening...